Skip to main content
. Author manuscript; available in PMC: 2023 Aug 21.
Published in final edited form as: Urol Oncol. 2022 Apr 14;40(5):199.e15–199.e21. doi: 10.1016/j.urolonc.2022.03.013

Fig. 1.

Fig. 1.

(A) Comparison of proportion of clinical trial enrollment vs. proportion of cancer incidence by sex for kidney cancer trials. (B) Comparison of proportion of clinical trial enrollment vs. proportion of cancer incidence by sex for bladder cancer trials. (C) Comparison of proportion of clinical trial enrollment vs. proportion of cancer Incidence by race/ethnicity for kidney cancer trials. (D) Comparison of proportion of clinical trial enrollment vs. proportion of cancer incidence by race/ethnicity for bladder cancer trials.